KCT0012241招募中不适用
A 12-week, Randomized, Double-blind, Placebo-controlled Human Study to Evaluate the Safety and Efficacy of the Probiotic Combination of L. reuteri CKDB010 and B. longum NBM7-1 (CKDB-344) for Improving Muscle Strength and Physical Function
Woosuk University Korean Medicine Medical Center0 个研究点目标入组 100 人开始时间: 2026年6月19日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 主要目的
- Supportive Care
入排标准
- 年龄范围
- 50(Year) 至 85(Year)（—）
- 性别
- All
入选标准
- •Subjects who voluntarily provided written informed consent after receiving a full explanation of the study
- •Male and female adults aged 50 to 85 years at the time of providing written informed consent
- •Subjects with a body mass index (BMI) =18.5 kg/m² and <30.0 kg/m²
- •Subjects with handgrip strength below the age-specific reference value
- •Subjects with a Short Physical Performance Battery (SPPB) score >9
排除标准
- •Subjects with a history of fragility hip fracture
- •Subjects with any of the following conditions, medical histories, or surgical histories: musculoskeletal disorders, neurological disorders, uncontrolled hypertension, uncontrolled diabetes mellitus, taking medications for the treatment of psychiatric disorders, gastrointestinal disorders that may affect the ingestion or absorption of the investigational product, etc
- •Heavy smokers
- •Subjects with hypersensitivity to any component of the investigational product or a history of allergy that, in the investigator's judgment, makes participation in the study inappropriate
- •Subjects who participated in another clinical study and received an investigational product, investigational food, investigational medical device within 3 months prior to screening
- •Subjects who, in the investigator's judgment, are considered unsuitable for participation in the study for any other reason
- •Pregnant or lactating women
- •Women of childbearing potential and men who are unable or unwilling to use appropriate methods of contraception during the study period
研究组 & 干预措施
Dietary Supplement : Test Product: Capsules containing CKDB-344
干预措施: Dietary Supplement : Test Product: Capsules containing CKDB-344
研究者
相似试验
招募中
1 期
A Pilot, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of a Single Intra-articular Injection of CNTX-0066 in Participants with Chronic, Moderate-to-Severe Osteoarthritis Knee PainOsteoarthritis of the knee2025-523737-26-00Centrexion Therapeutics Corp.20
招募中
1 期
A Randomized, Placebo-controlled, Double-blind, Dose-finding Phase 1b Study to Assess the Safety, Immunogenicity and Pharmacodynamics of TRB-001 in Early Idiopathic Parkinson’s Disease PatientsParkinson's disease2024-519123-14-00Tridem Bioscience FlexCo18
招募中
不适用
A Phase 2 study of naldemedine in participants with constipation associated with Parkinson's diseaseConstipation associated with Parkinson's diseasejRCT203126006040
招募中
1 期
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATX304Obesity/overweight (healthy subjects)2024-514744-91-00Betagenon AB, Betagenon AB40
招募中
1 期
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Adaptive Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CLE-905-AG, a M1/M4 Muscarinic Agonist when administered alone or in conjunction with a Peripheral Muscarinic antagonist, in Healthy ParticipantsSchizophrenia2025-521914-25-00Clexio Biosciences Ltd.110